36 studies found for:    Open Studies | "Acromegaly"
Show Display Options
Rank Status Study
21 Recruiting Acromegaly Combination Treatment Study
Condition: Acromegaly
Interventions: Drug: Pegvisomant;   Drug: Somatostatin Receptor Ligand (SRL)
22 Unknown  Measurement of Outcome of Surgical Treatment in Patients With Acromegaly
Condition: Acromegaly
Intervention:
23 Unknown  Growth Hormone Feedback to Insulin-like Growth Factor-I (IGF-1) and Oral Glucose Tolerance Test (OGTT)
Conditions: Acromegaly;   Type 2 Diabetes Mellitus
Interventions: Other: oral glucose tolerance test;   Other: Subcutaneous administration of recombinant human IGF-1
24 Recruiting Acromegaly Treatment Quality of Life Study
Condition: Acromegaly
Intervention:
25 Not yet recruiting Predictive Factors Study
Condition: Acromegaly
Intervention: Drug: Somatuline Autogel® (lanreotide) 60, 90, 120 mg.
26 Recruiting Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA
Conditions: Acromegaly;   Gigantism;   Familial Isolated Pituitary Adenoma;   FIPA;   Pituitary Adenoma Predisposition;   PAP
Intervention:
27 Unknown  Tissue Biomarker for Pegvisomant Action
Condition: Acromegaly
Intervention: Drug: Pegvisomant
28 Recruiting The Observational Study of Growth Hormone-secreting Pituitary Tumors
Conditions: Acromegaly;   Pituitary Tumor
Intervention:
29 Unknown  Oral Glucose Tolerance Testing (OGTT) on Patients Taking Somatostatin Analogs
Condition: Acromegaly
Intervention: Other: Oral Glucose Tolerance Test (OGTT)
30 Unknown  Preoperative Lanreotide Treatment in Acromegalic Patients With Macroadenomas
Condition: Acromegaly
Interventions: Drug: Preoperative lanreotide treatment;   Procedure: Transsphenoidal surgery
31 Recruiting Substrate Metabolism and Insulin Sensitivity in Acromegalic Patients Before and After Treatment
Conditions: Acromegaly;   Growth Hormone;   Insulin Resistance
Intervention: Procedure: Transsphenoidal adenomectomy
32 Recruiting Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in a Novartis-sponsored Study.
Conditions: Cushing's Disease,;   Acromegaly,;   Neuroendocrine Tumors,;   Pituitary Tumors;   Ectopic ACTH Secreting (EAS) Tumors,;   Dumping Syndrome,;   Prostate Cancer,;   Melanoma Negative for bRAF,;   Melanoma Negative for nRAS
Intervention: Drug: Pasireotide
33 Unknown  Estrogen Treatment in Acromegalic Women
Condition: Acromegaly
Intervention: Drug: Alesse
34 Recruiting A Pilot Study of Pre- and Post-operative Use of Somatuline Depot.
Condition: Acromegaly
Intervention: Drug: lanreotide
35 Recruiting Phase II Study With ITF2984 in Acromegalic Patients
Condition: Active Acromegaly
Interventions: Drug: Octreotide;   Drug: ITF2984 500 mcg;   Drug: ITF2984 1000 mcg;   Drug: ITF2984 2000 mcg
36 Recruiting Prevalence of Pituitary Incidentaloma in Relatives of Patients With Pituitary Adenoma
Condition: Pituitary Tumor
Intervention:

Show previous page of results Previous Page (1-20) Studies Shown (21-36) Next Page
Indicates status has not been verified in more than two years